CXCR2 and colorectal carcinoma: We discovered that chemotherapy-induced CXCL7 expression in TAMs contributes to resistance by activating the CXCL7/CXCR2 axis in CRC cells, which in turn enhances serine metabolism through the upregulation of PHGDH.